Literature DB >> 8471436

Frequency of adult T-cell leukaemia/lymphoma and HTLV-I in Ibadan, Nigeria.

C K Williams1, S S Alexander, A Bodner, A Levine, C Saxinger, R C Gallo, W A Blattner.   

Abstract

Sera from a small sample of adult blood donors, healthy school children and patients with lymphoma, leukaemia, non-haematologic cancer, congenital and inflammatory disorders from Ibadan, Nigeria were screened for HTLV-I antibody by an enzyme-linked immunoabsorbent assay and confirmed by investigational Western blot. Seventy-nine of 236 positively screened samples could not be tested for confirmation. Seropositive reactivity was observed in nine of 123 blood donors, and 3 of 46 healthy school children but banding patterns on Western blot were often sparse. Among non-Burkitt's non Hodgkin's lymphoma patients six of 30 were HTLV-I positive including four of four with clinical features of adult T-cell leukaemia (ATL). Other clinical conditions had a frequency of positivity indistinguishable from healthy donors. Western blot patterns ranged from strong with multiple bands, which were uncommon, to those with only p24 and p21 envelope positive which were frequent. Given the relative paucity of clinical ATL and the unusual Western blot patterns the true rate of HTLV-I infection may be lower than estimated. It is possible that a cross-reactive HTLV-I-like virus accounts for this pattern.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471436      PMCID: PMC1968344          DOI: 10.1038/bjc.1993.142

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Distinguishing between HTLV-I and HTLV-II by western blot.

Authors:  S Z Wiktor; S S Alexander; G M Shaw; S H Weiss; E L Murphy; R J Wilks; V J Shortly; B Hanchard; W A Blattner
Journal:  Lancet       Date:  1990-06-23       Impact factor: 79.321

2.  HTLV-I infection in western equatorial Africa.

Authors:  E Delaporte; M Peeters; M Simoni; P Piot
Journal:  Lancet       Date:  1989-11-18       Impact factor: 79.321

3.  Lack of HTLV-I antibodies in Africans.

Authors:  R A Weiss; R Cheingsong-Popov; S Clayden; S Pegram; R S Tedder; A Barzilai; E Rubenstein
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

4.  Epidemiology of HTLV-I in Gabon (Western Equatorial Africa).

Authors:  E Delaporte; A Dupont; M Peeters; R Josse; M Merlin; D Schrijvers; B Hamono; L Bedjabaga; H Cheringou; F Boyer
Journal:  Int J Cancer       Date:  1988-11-15       Impact factor: 7.396

5.  Licensure of screening tests for antibody to human T-lymphotropic virus type I.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1988-12-09       Impact factor: 17.586

6.  ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans.

Authors:  R J Biggar; P L Gigase; M Melbye; L Kestens; P S Sarin; A J Bodner; P Demedts; W J Stevens; L Paluku; C Delacollette
Journal:  Lancet       Date:  1985-09-07       Impact factor: 79.321

7.  Human T cell leukaemia virus associated lymphoproliferative disease: report of two cases in Nigeria.

Authors:  C K Williams; G O Alabi; T A Junaid; C Saxinger; R C Gallo; D W Blayney; W A Blattner; M F Greaves
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

8.  Human T-cell leukemia virus (HTLV-I) antibodies in Africa.

Authors:  W Saxinger; W A Blattner; P H Levine; J Clark; R Biggar; M Hoh; J Moghissi; P Jacobs; L Wilson; R Jacobson
Journal:  Science       Date:  1984-09-28       Impact factor: 47.728

9.  Non-Hodgkin lymphoma in Jamaica and its relation to adult T-cell leukemia-lymphoma.

Authors:  W N Gibbs; W S Lofters; M Campbell; B Hanchard; L LaGrenade; B Cranston; J Hendriks; E S Jaffe; C Saxinger; M Robert-Guroff
Journal:  Ann Intern Med       Date:  1987-03       Impact factor: 25.391

10.  Antibodies to HTLV-I in Nigerian blood-donors, their relatives and patients with leukaemias, lymphomas and other diseases.

Authors:  A F Fleming; R Maharajan; M Abraham; A G Kulkarni; S R Bhusnurmath; R A Okpara; E Williams; I Akinsete; J Schneider; H Bayer
Journal:  Int J Cancer       Date:  1986-12-15       Impact factor: 7.396

View more
  3 in total

1.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

2.  Prevalence of human T-lymphotropic virus 1/2 in Nigeria's capital territory and meta-analysis of Nigerian studies.

Authors:  Nneoma Confidence JeanStephanie Anyanwu; Elijah Ekah Ella; Maryam Aminu; Maleeha Azam; Muhammad Ajmal; Haruna Makonjuola Kazeem
Journal:  SAGE Open Med       Date:  2019-04-16

Review 3.  Seroprevalence of HTLV-1 and HTLV-2 amongst mothers and children in Malawi within the context of a systematic review and meta-analysis of HTLV seroprevalence in Africa.

Authors:  James M Fox; Nora Mutalima; Elizabeth Molyneux; Lucy M Carpenter; Graham P Taylor; Martin Bland; Robert Newton; Fabiola Martin
Journal:  Trop Med Int Health       Date:  2016-02-03       Impact factor: 2.622

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.